CYP2C9 and stroke disorder: Additionally, CYP2C9 polymorphisms are associated with enhanced vulnerability of atherosclerotic plaques and elevated risk of embolic stroke, potentially mediated by disrupted eicosanoid metabolism that exacerbates vascular inflammation and endothelial dysfunction [16,17].